Titusville, NJ, United States of America

Justine M Kent

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Justine M Kent: Innovator in Depression Treatment

Introduction

Justine M Kent is a notable inventor based in Titusville, NJ (US). She has made significant contributions to the field of medicine, particularly in the treatment of depression. With a total of 3 patents to her name, her work focuses on innovative methods that aim to improve the quality of life for individuals suffering from mental health issues.

Latest Patents

Among her latest patents is a groundbreaking method of treating depression using orexin-2 receptor antagonists. This patent outlines a process for administering an effective amount of a specific compound to subjects diagnosed with depression, particularly before sleep. The compound, described in the patent, is designed to alleviate symptoms of depression, showcasing her commitment to advancing mental health treatments.

Career Highlights

Justine M Kent is currently associated with Janssen Pharmaceutica NV, where she continues her research and development efforts. Her work at this esteemed company allows her to collaborate with other experts in the field, further enhancing her contributions to medical science.

Collaborations

Some of her notable coworkers include Peter De Boer and Wayne C Drevets. Their collaboration fosters a dynamic environment for innovation and research, leading to advancements in treatment methodologies.

Conclusion

Justine M Kent's innovative work in the treatment of depression highlights her dedication to improving mental health care. Her patents and ongoing research at Janssen Pharmaceutica NV position her as a key figure in the field of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…